<DOC>
	<DOCNO>NCT02467647</DOCNO>
	<brief_summary>To investigate efficacy combination Thalidomide Huang-Lian-Jie-Du-Tang patient multiple myeloma maintain therapy .</brief_summary>
	<brief_title>The Effects Huang-Lian-Jie-Du-Tangï¼ˆHLJDT ) Survival Patients With Multiple Myeloma Maintain Therapy</brief_title>
	<detailed_description />
	<mesh_term>Multiple Myeloma</mesh_term>
	<mesh_term>Neoplasms , Plasma Cell</mesh_term>
	<mesh_term>Thalidomide</mesh_term>
	<mesh_term>Oren gedoku</mesh_term>
	<criteria>patient take HLJDT patient take HLJDT</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>